Pharmacology of Nimodipine

Annals of the New York Academy of SciencesVolume 522, Issue 1 p. 698-706 Pharmacology of Nimodipine A Review A. SCRIABINE, A. SCRIABINE Institute for Preclinical Pharmacology Miles, Inc. Post Office Box 1956 New Haven, Connecticut 06509Search for more papers by this authorW. van den KERCKHOFF, W. van den KERCKHOFF Pharmacological Institute Bayer AG D-5600 Wuppertal, Federal Republic of GermanySearch for more papers by this author A. SCRIABINE, A. SCRIABINE Institute for Preclinical Pharmacology Miles, Inc. Post Office Box 1956 New Haven, Connecticut 06509Search for more papers by this authorW. van den KERCKHOFF, W. van den KERCKHOFF Pharmacological Institute Bayer AG D-5600 Wuppertal, Federal Republic of GermanySearch for more papers by this author First published: March 1988 https://doi.org/10.1111/j.1749-6632.1988.tb33415.xCitations: 78AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat Citing Literature Volume522, Issue1Calcium Antagonists: Pharmacology and Clinical ResearchMarch 1988Pages 698-706 RelatedInformation